Rossari Biotech Ltd
ROSSARIRossari Biotech Ltd
ROSSARI


Price Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
26.55 | 3.45 | 0.08% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
27.80 | 3.16 | 1.50% |
Forecast & Ratings
Detailed Forecast from 3 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Rossari Biotech is engaged in business of textile and specialty chemical manufacturing.
Investor Presentation
View olderÂPeers
Compare with peersÂGet more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 517.13 | 603.81 | 718.47 | 1,496.51 | 1,662.32 | 1,838.18 | 1,977.07 | |||||||
Raw Materials | 355.23 | 369.26 | 470.62 | 1,128.08 | 1,183.96 | 1,357.04 | 1,714.26 | |||||||
Power & Fuel Cost | 1.26 | 1.74 | 2.40 | 11.92 | 20.40 | 23.30 | ||||||||
Employee Cost | 27.52 | 37.21 | 41.98 | 67.93 | 98.62 | 103.13 | ||||||||
Selling & Administrative Expenses | 38.07 | 50.79 | 36.70 | 37.93 | 58.89 | 61.54 | ||||||||
Operating & Other expenses | 16.59 | 36.57 | 34.11 | 53.67 | 71.00 | 35.79 | ||||||||
EBITDA | 78.46 | 108.24 | 132.66 | 196.98 | 229.45 | 257.38 | 262.81 | |||||||
Depreciation/Amortization | 12.19 | 16.85 | 22.83 | 48.06 | 62.93 | 60.39 | 64.92 | |||||||
PBIT | 66.27 | 91.39 | 109.83 | 148.92 | 166.52 | 196.99 | 197.89 | |||||||
Interest & Other Items | 2.88 | 3.56 | 2.99 | 12.66 | 22.32 | 19.37 | 14.83 | |||||||
PBT | 63.39 | 87.83 | 106.84 | 136.26 | 144.20 | 177.62 | 183.06 | |||||||
Taxes & Other Items | 17.71 | 22.58 | 26.62 | 38.60 | 36.96 | 46.93 | 46.98 | |||||||
Net Income | 45.68 | 65.25 | 80.22 | 97.66 | 107.24 | 130.69 | 136.08 | |||||||
EPS | 9.44 | 13.16 | 15.62 | 18.26 | 19.46 | 23.68 | 24.63 | |||||||
DPS | 0.00 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | |||||||
Payout ratio | 0.00 | 0.04 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 |
Company Updates
Peers & Comparison
MaterialsSpecialty Chemicals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Rossari Biotech Ltd | 27.65 | 3.45 | 0.08% |
Gujarat Fluorochemicals Ltd | 95.27 | 6.98 | 0.08% |
Navin Fluorine International Ltd | 75.32 | 8.55 | 0.36% |
Vinati Organics Ltd | 52.81 | 6.93 | 0.43% |
Price Comparison
Compare ROSSARI with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Rossari Biotech Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 3.9337% | Percentage of the fund’s portfolio invested in the stock 0.47% | Change in the portfolio weight of the stock over the last 3 months -0.03% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 61/65 (-4) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 3.4767% | Percentage of the fund’s portfolio invested in the stock 0.52% | Change in the portfolio weight of the stock over the last 3 months -0.04% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 52/67 (-1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 2.2657% | Percentage of the fund’s portfolio invested in the stock 0.67% | Change in the portfolio weight of the stock over the last 3 months -0.03% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 91/105 (-2) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividend Cuts
ROSSARI has increased or maintained dividend levels over the last 5 years
Dividend Yield
Current dividend yield is 0.07%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹0.74 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateAug 16, 2024
Dividend/Share
₹0.50
Ex DateEx Date
Aug 16, 2024
Cash Dividend
Ex DateEx DateMay 24, 2023
Dividend/Share
₹0.50
Ex DateEx Date
May 24, 2023
Cash Dividend
Ex DateEx DateJul 7, 2022
Dividend/Share
₹0.50
Ex DateEx Date
Jul 7, 2022
Cash Dividend
Ex DateEx DateSep 8, 2021
Dividend/Share
₹0.50
Ex DateEx Date
Sep 8, 2021
However, revenue from operations jumped 10.55% to Rs 512.73 crore in the third quarter of FY25 as against Rs 463.77 crore posted in the corresponding quarter last year. Profit before tax stood at Rs 42.38 crore in the quarter ended 31 December 2024, down 11.30% as against Rs 47.78 crore recorded in Q3 FY24. Total expenses advanced 12.32% to Rs 471.23 crore during the quarter. Cost of material consumed stood at Rs 321.48 crore (down 17.78% YoY), employee benefit expenses stood at Rs 35.69 crore (up 37.07%) while finance cost was at Rs 4.94 crore (up 14.35% YoY), during the period under review. On nine-month basis, the company's standalone net profit rose 5.56% to Rs 101.93 crore on 10.52% increase in revenue to Rs 1,500.7 crore in 9M FY25 over 9M FY24. Rossari Biotech is a specialty chemical manufacturer and offers tailor-made solutions for home, personal care and performance chemicals (HPPC), textile speciality chemicals and animal health and nutrition (AHN). Powered by Capital Market - Live
Net profit of Rossari Biotech declined 7.82% to Rs 31.70 crore in the quarter ended December 2024 as against Rs 34.39 crore during the previous quarter ended December 2023. Sales rose 10.56% to Rs 512.73 crore in the quarter ended December 2024 as against Rs 463.77 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales512.73463.77 11 OPM %12.6313.73 - PBDT60.7062.87 -3 PBT42.3847.78 -11 NP31.7034.39 -8 Powered by Capital Market - Live
The board of Rossari Biotech at its meeting held on 21 January 2025 has approved change in registered office from 201 A - B, 2nd Floor, Akruti Corporate Park, L.B.S Marg, Next to GE Gardens, Kanjurmarg (W), Mumbai - 400078 to Rossari House, Golden Oak, LBS Marg, Surya Nagar, Opp. Mahindra Showroom, Vikhroli (West), Mumbai Maharashtra, India, 400079 effective from 01 February 2025. Powered by Capital Market - Live
Rossari Biotech has allotted 7,500 equity shares under ESOP on 21 January 2025. Consequently, the paid up equity share capital has increased to Rs. 11,07,27,532 consisting of 55363766 equity shares of Rs. 2/- each.Powered by Capital Market - Live
Rossari Biotech will hold a meeting of the Board of Directors of the Company on 21 January 2025.Powered by Capital Market - Live
Rossari Biotech announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 11 November 2024 .Powered by Capital Market - Live
Net profit of Rossari Biotech rose 7.22% to Rs 35.33 crore in the quarter ended September 2024 as against Rs 32.95 crore during the previous quarter ended September 2023. Sales rose 3.08% to Rs 498.35 crore in the quarter ended September 2024 as against Rs 483.47 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales498.35483.47 3 OPM %13.2313.15 - PBDT63.2759.92 6 PBT48.1144.81 7 NP35.3332.95 7 Powered by Capital Market - Live
Rossari Biotech will hold a meeting of the Board of Directors of the Company on 19 October 2024.Powered by Capital Market - Live
Glenmark Life Sciences Ltd leads gainers in ‘A’ group

Rossari Biotech Q1 Results Review - Steady Performance: ICICI Securities

Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 28.87%, vs industry avg of 6.14%
Increasing Market Share
Over the last 5 years, market share increased from 0.93% to 2.13%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 23.4%, vs industry avg of -1.48%